Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients

Lupus

Volumn 21, Issue 10, 2012, Pages 1098-1104

  Hermansen, M L F ^a   Hummelshoj L ^b   Lundsgaard, D ^c   Hornum, L ^c   Keller, P ^c   Fleckner, J ^c   Fox, B ^b   Poulsen, L K ^b   Jacobsen, S ^a  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

2 microglobulin; disease activity; IFN ; IL 10; IL 18; IL 6; IL 8; SLE; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; BETA 2 MICROGLOBULIN; COMPLEMENT COMPONENT C3; DOUBLE STRANDED DNA ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COMPLEMENT C3; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; YOUNG ADULT;

EID: 84865081212     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312447668     Document Type: Article

References (36)

1. Kyttaris VC, Krishnan S, Tsokos GC. Systems biology in systemic lupus erythematosus: integrating genes, biology and immune function. Autoimmunity. 2006 ; 39: 705-709
2. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
3. Sabry A, Sheashaa H, El-Husseini A, et al. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: Its correlation with disease activity. Cytokine. 2006 ; 35: 148-153
4. Chun HY, Chung JW, Kim HA, et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol. 2007 ; 27: 461-466
5. Gröndal G, Gunnarsson I, Rönnelid J, et al. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 2000 ; 18: 565-570
6. Amerio P, Frezzolini A, Abeni D, et al. Increased IL-18 in patients with systemic lupus erythematosus: Relations with Th-1, Th-2, proinflammatory cytokines and disease activity. Il-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol. 2002 ; 20: 535-538
7. Wong CK, Li EK, Ho CY, et al. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology (Oxford). 2000 ; 39: 1078-1081
8. Bengtsson AA, Sturfelt G, Truedsson L, et al. Activation of type 1 Interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus. 2000 ; 9: 664-671
9. Lit LC, Wong CK, Tam LS, et al. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis. 2006 ; 65: 209-215
10. Monrad S, Kaplan MJ. Dendritic cells and the Immunopathogenesis of systemic lupus erythematosus. Immunol Res. 2007 ; 37: 135-145
11. Evrin PE, Pertoft H. β2-microglobulin in human blood cells. J Immunol. 1973 ; 111: 1147-1154
12. Grey HM, Kubo RT, Colon SM, et al. The small subunit of HL-A antigens is β2-microglobulin. J Exp Med. 1973 ; 138: 1608-1612
13. Creswell P, Springer T, Stromninger JL, et al. Immunological identity of the small subunit of HL-A antigens and β2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci USA. 1974 ; 71: 2123-2127
14. Evrin PE, Strom T. Beta 2-microglobulin and its binding activity in serum from patients with SLE. Ann Rheum Dis. 1984 ; 43: 267-274
15. Yeung CK, Wong KL, Wong WS, et al. Beta 2-microglobulin and systemic lupus erythematosus. J Rheumatol. 1986 ; 13: 1053-1058
16. Kim HA, Jeon JY, Yoon JM, et al. Beta2-microglobulin can be a disease activity marker in systemic lupus erythematosus. Am J Med Sci. 2010 ; 339: 337-340
17. Font J, Coca A, Molina R, et al. Serum beta2-microglobulin as a marker of activity in systemic lupus erythematosus. Scand J Rheumatol. 1986 ; 15: 201-205
18. Wibell LB. Studies on beta2-microglobulin in patients and normal subjects. Acta Clin Belg. 1976 ; 31: 14-26
19. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
20. Lleonart R, Dieter N, Browning H, et al. A novel, quantitative bioassay for type 1 interferon using a recombinant indicator cell line. Nat Biotechnol. 1990 ; 8: 1263-1267
21. Ho A, Magder LS, Barr SG, et al. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum. 2001 ; 44: 2342-2349
22. Jacobsen S, Petersen J, Ullman S, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol. 1998 ; 17: 468-477
23. Cooper EH, Plesner T. Beta-2-microglobulin review: its relevance in clinical oncology. Med Pediatr Oncol. 1980 ; 8: 323-334
24. Spronk PE, Ter Borg EJ, Limburg PC, et al. Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?. Clin Exp Immunol. 1992 ; 90: 106-110
25. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol. 1999 ; 103: 11-24
26. Dinarello CA, Novick D, Puren AJ, et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol. 1998 ; 63: 658-664
27. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA. 1992 ; 89: 1890-1893
28. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991 ; 146: 3444-3451
29. Ling GS, Cook HT, Botto M, et al. An essential protective role of IL-10 in the immunological mechanism underlying resistance vs susceptibility to lupus induction by dendritic cells and dying cells. Rheumatology (Oxford) 2011; 50: 1773-1784.
30. Theofilopoulos AN, Baccala R, Beutler B, et al. Type 1 interferons (α/β) in immunity and autoimmunity. Ann Rev Immunol. 2005 ; 23: 307-336
31. Baccala R, Hoebe K, Kono DH, et al. Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type 1 interferon induction in systemic autoimmunity. Nat Med. 2007 ; 13: 543-551
32. Remes K, Tienhaara A, Pelliniemi TT. Effects of alpha-interferon on serum beta-2-microglobulin. Leuk Lymphoma. 1996 ; 21: 233-238
33. Dall'Era MC, Cardarelli PM, Preston BT, et al. Type I interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis. 2005 ; 64: 1692-1697
34. Kippner L, Klint C, Sturfelt G, et al. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia. J Autoimmun. 2001 ; 16: 471-478
35. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA. 2003 ; 100: 2610-2615
36. Bennet L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003 ; 197: 711-723